BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $38,660 | -49.4% | 1,000 | -50.6% | 0.01% | -58.3% |
| Q3 2023 | $76,461 | -17.2% | 2,026 | 0.0% | 0.01% | -14.3% |
| Q2 2023 | $92,305 | -31.6% | 2,026 | -39.1% | 0.01% | -36.4% |
| Q1 2023 | $134,903 | +78790.6% | 3,326 | -0.9% | 0.02% | -18.5% |
| Q4 2022 | $171 | -99.9% | 3,356 | -8.2% | 0.03% | -18.2% |
| Q3 2022 | $197,000 | -13.6% | 3,656 | +2.8% | 0.03% | -10.8% |
| Q2 2022 | $228,000 | -12.6% | 3,556 | +6.0% | 0.04% | 0.0% |
| Q1 2022 | $261,000 | -10.9% | 3,356 | -1.6% | 0.04% | -28.8% |
| Q4 2021 | $293,000 | -18.6% | 3,412 | -23.9% | 0.05% | -21.2% |
| Q3 2021 | $360,000 | -4.8% | 4,481 | 0.0% | 0.07% | +3.1% |
| Q1 2021 | $378,000 | -1.8% | 4,481 | -6.6% | 0.06% | -7.2% |
| Q4 2020 | $385,000 | +28.3% | 4,796 | +28.7% | 0.07% | +19.0% |
| Q3 2020 | $300,000 | -4.2% | 3,727 | +2.6% | 0.06% | -12.1% |
| Q2 2020 | $313,000 | +6.1% | 3,632 | 0.0% | 0.07% | -2.9% |
| Q1 2020 | $295,000 | -3.0% | 3,632 | 0.0% | 0.07% | +21.4% |
| Q4 2019 | $304,000 | -4.4% | 3,632 | 0.0% | 0.06% | -13.8% |
| Q3 2019 | $318,000 | +3.9% | 3,632 | -2.7% | 0.06% | +4.8% |
| Q2 2019 | $306,000 | +1.0% | 3,732 | 0.0% | 0.06% | +6.9% |
| Q1 2019 | $303,000 | +6.7% | 3,732 | -13.7% | 0.06% | -7.9% |
| Q4 2018 | $284,000 | -14.7% | 4,322 | 0.0% | 0.06% | -7.4% |
| Q3 2018 | $333,000 | +4.4% | 4,322 | 0.0% | 0.07% | -1.4% |
| Q2 2018 | $319,000 | +13.5% | 4,322 | 0.0% | 0.07% | +9.5% |
| Q1 2018 | $281,000 | +0.7% | 4,322 | 0.0% | 0.06% | -1.6% |
| Q4 2017 | $279,000 | +3.0% | 4,322 | 0.0% | 0.06% | 0.0% |
| Q3 2017 | $271,000 | -0.7% | 4,322 | -4.2% | 0.06% | -7.2% |
| Q2 2017 | $273,000 | -55.2% | 4,512 | -67.0% | 0.07% | -19.8% |
| Q1 2017 | $610,000 | +193.3% | 13,656 | +191.2% | 0.09% | +59.3% |
| Q4 2016 | $208,000 | -4.6% | 4,689 | +2.2% | 0.05% | -12.9% |
| Q3 2016 | $218,000 | -39.3% | 4,589 | -42.3% | 0.06% | -41.5% |
| Q2 2016 | $359,000 | -3.5% | 7,949 | -12.3% | 0.11% | -10.2% |
| Q1 2016 | $372,000 | -6.5% | 9,066 | -13.2% | 0.12% | -7.1% |
| Q4 2015 | $398,000 | -65.3% | 10,442 | -70.1% | 0.13% | -65.8% |
| Q3 2015 | $1,148,000 | -26.0% | 34,960 | +57.5% | 0.37% | -12.1% |
| Q2 2015 | $1,552,000 | +2.2% | 22,203 | +0.1% | 0.42% | +11.1% |
| Q1 2015 | $1,519,000 | -99.9% | 22,175 | -46.4% | 0.38% | -7.5% |
| Q4 2014 | $1,360,729,000 | +86792.0% | 41,333 | +89.5% | 0.41% | +0.2% |
| Q3 2014 | $1,566,000 | -0.8% | 21,815 | -0.0% | 0.41% | +5.1% |
| Q2 2014 | $1,578,000 | +2.6% | 21,823 | -1.3% | 0.39% | -2.0% |
| Q4 2013 | $1,538,000 | +20.2% | 22,106 | +13.4% | 0.40% | +11.2% |
| Q3 2013 | $1,280,000 | -5.7% | 19,495 | -0.6% | 0.36% | -12.9% |
| Q2 2013 | $1,358,000 | – | 19,608 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |